当前位置:首页 > 文献互助 > 互助详情

Condrosulf®: structural characterization, pharmacological activities and mechanism of action复制

用户f9o2xraq7l_c 1天前 18 10 已关闭

DOI:复制

文献链接:复制

其他信息:

N Volpi
Current Medicinal Chemistry, 2014
benthamdirect.com
Condrosulf® is a pharmaceutical formulation containing chondroitin sulfate (CS) as an active component possessing high quality and purity and standardized properties. CS is currently applied as a SYSADOA (Symptomatic Slow Acting Drug for Osteoarthritis) agent in Europe in the treatment of osteoarthritis (OA). Furthermore, Condrosulf® and pharmaceutical grade CS have also been proven to possess structure-modifying effects belonging to the S/DMOAD (structure/disease modifying anti-osteoarthritis drug) class. This review …

互助时间线

2025-12-08 17:03:00 [关闭求助]

楼主用户f9o2xraq7l_c关闭了求助

2025-12-08 16:06:37 [发起求助]

最新发布的求助